Cannabis e-commerce company Herbal Dispatch (CSE:HERB) grew sales by 38 per cent in 2025, marking its third-straight year of double-digit sales growth, setting a prospective tone for 2026. Preliminary gross sales for fiscal 2025 are estimated at C$16.5 million, up from C$12 million year-over-year (YoY) – including Q4 sales of C$6.2 million, up by 214 per cent from C$2.9 million YoY – driven by new flower, pre-roll and vape product introductions into the Canadian market, as well as an oversubscribed C$2 million private placement in October to bankroll growth initiatives.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | MediPharm Labs to enter new market with Costa Rica supply agreement
2 | Curaleaf celebrates opening of Lauderhill, Florida dispensary
3 | Tilray scores record Q2 fiscal 2026 net revenue, moves to net cash position
4 | Aurora achieves significant progress in disease resistance research
Top Cannabis Stocks Jan. 9 to Jan. 15, 2026
1. T.CURA | 8,276 views | Curaleaf Holdings Inc.
2. T.TLRY | 7,521 views | Tilray Brands Inc.
3. T.LABS | 3,476 views | Medipharm Labs Corp.
4. C.TGIF | 696 views | 1933 Industries Inc.
5. C.BLO | 505 views | Cannabix Technologies Inc.
6. T.OGI | 405 views | Organigram Global Inc.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
